A Comparative Study Of Iodine I 131 Tositumomab Therapeutic Regimen Versus Ibritumomab Tiuxetan Therapeutic Regimen

Clinical trial NCT00319332 · WITHDRAWN

Trial details

NCT number: NCT00319332
Sponsor: GlaxoSmithKline
Status: WITHDRAWN
Phase: Phase 3
Study type: INTERVENTIONAL

Lymphoma, Small Cleaved-Cell, Follicular Lymphoma, Large-Cell, Follicular Lymphoma, Follicular Lymphoma, Non-Hodgkin

Start date: 2005-09-01
Primary completion: 2021-02-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.